SEC Form 4 · accession 0001144204-17-047125
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard G Johnson
Officer — Chief Financial Officer
Period of report
Sep 5, 2017
Accepted (ET)
Sep 7, 2017 · 9:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Sep 5, 2017 | M | 4,240 | $11.83 | A | 4,240 | D | |
| Class A Common StockF2 | Sep 5, 2017 | S | 4,240 | $35.56 | D | 0 | D | |
| Class A Common Stock | Sep 5, 2017 | M | 764 | $11.83 | A | 764 | D | |
| Class A Common StockF3 | Sep 5, 2017 | S | 764 | $36.54 | D | 0 | D | |
| Class A Common Stock | Sep 6, 2017 | M | 5,664 | $11.83 | A | 5,664 | D | |
| Class A Common StockF4 | Sep 6, 2017 | S | 5,664 | $35.05 | D | 0 | D | |
| Class A Common Stock | Sep 7, 2017 | M | 15,941 | $11.83 | A | 15,941 | D | |
| Class A Common StockF5 | Sep 7, 2017 | S | 15,941 | $35.77 | D | 0 | D | |
| Class A Common Stock | Sep 7, 2017 | M | 3,198 | $11.83 | A | 3,198 | D | |
| Class A Common StockF6 | Sep 7, 2017 | S | 3,198 | $36.08 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Common Stock | $11.83 | Sep 5, 2017 | M | 5,004 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 5,004 | 61,296 | D |
| Option to purchase Common Stock | $11.83 | Sep 6, 2017 | M | 5,664 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 5,664 | 55,632 | D |
| Option to purchase Common Stock | $11.83 | Sep 7, 2017 | M | 19,139 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 19,139 | 36,493 | D |
Explanation of responses
- F1The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.20 to $36.15, inclusive.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.45 to $36.65, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.25, inclusive.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.95, inclusive.
- F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.15, inclusive.